152 related articles for article (PubMed ID: 34252916)
1. Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine.
Al-Karagholi MA; Ghanizada H; Waldorff Nielsen CA; Skandarioon C; Snellman J; Lopez-Lopez C; Hansen JM; Ashina M
Pain; 2021 Oct; 162(10):2512-2520. PubMed ID: 34252916
[TBL] [Abstract][Full Text] [Related]
2. Opening of BK
Al-Karagholi MA; Ghanizada H; Nielsen CAW; Skandarioon C; Snellman J; Lopez Lopez C; Hansen JM; Ashina M
Cephalalgia; 2020 Oct; 40(11):1145-1154. PubMed ID: 32847403
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity to BK
Al-Khazali HM; Christensen RH; Dodick DW; Chaudhry BA; Melchior AG; Burstein R; Ashina H
J Headache Pain; 2024 Jun; 25(1):102. PubMed ID: 38890563
[TBL] [Abstract][Full Text] [Related]
4. Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine.
Al-Karagholi MA; Hansen JM; Guo S; Olesen J; Ashina M
Brain; 2019 Sep; 142(9):2644-2654. PubMed ID: 31292608
[TBL] [Abstract][Full Text] [Related]
5. Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial.
Kokoti L; Al-Karagholi MA; Zhuang ZA; Amirguliyev S; Amin FM; Ashina M
Cephalalgia; 2024 May; 44(5):3331024241248211. PubMed ID: 38729773
[TBL] [Abstract][Full Text] [Related]
6. The role of high-conductance calcium-activated potassium channel in headache and migraine pathophysiology.
Al-Karagholi MA; Hakbilen CC; Ashina M
Basic Clin Pharmacol Toxicol; 2022 Nov; 131(5):347-354. PubMed ID: 36028922
[TBL] [Abstract][Full Text] [Related]
7. Opening of ATP sensitive potassium channels causes migraine attacks with aura.
Al-Karagholi MA; Ghanizada H; Nielsen CAW; Hougaard A; Ashina M
Brain; 2021 Sep; 144(8):2322-2332. PubMed ID: 33768245
[TBL] [Abstract][Full Text] [Related]
8. Adenosine causes short-lasting vasodilation and headache but not migraine attacks in migraine patients: a randomized clinical trial.
Thuraiaiyah J; Al-Karagholi MA; Elbahi FA; Zhuang ZA; Ashina M
Pain; 2023 May; 164(5):1118-1127. PubMed ID: 36251971
[TBL] [Abstract][Full Text] [Related]
9. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial.
Pellesi L; Al-Karagholi MA; De Icco R; Coskun H; Elbahi FA; Lopez-Lopez C; Snellman J; Hannibal J; Amin FM; Ashina M
JAMA Netw Open; 2021 Aug; 4(8):e2118543. PubMed ID: 34357396
[TBL] [Abstract][Full Text] [Related]
10. PACAP38 induces migraine-like attacks in patients with migraine without aura.
Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M
Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139
[TBL] [Abstract][Full Text] [Related]
11. Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial.
Raffaelli B; Do TP; Chaudhry BA; Amin FM; Ashina H; Snellman J; Maio-Twofoot T; Ashina M
Cephalalgia; 2024 Jan; 44(1):3331024231222916. PubMed ID: 38181724
[TBL] [Abstract][Full Text] [Related]
12. Targeting BK
Al-Karagholi MA; Gram C; Nielsen CAW; Ashina M
CNS Drugs; 2020 Apr; 34(4):325-335. PubMed ID: 32060729
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache.
Al-Khazali HM; Christensen RH; Dodick DW; Chaudhry BA; Burstein R; Ashina H
Cephalalgia; 2023 Nov; 43(11):3331024231210930. PubMed ID: 37917826
[TBL] [Abstract][Full Text] [Related]
14. Effect of K
Al-Karagholi MA; Ghanizada H; Kokoti L; Paulsen JS; Hansen JM; Ashina M
Cephalalgia; 2020 Sep; 40(10):1045-1054. PubMed ID: 32806954
[TBL] [Abstract][Full Text] [Related]
15. Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries.
Al-Karagholi MA; Ghanizada H; Hansen JM; Skovgaard LT; Olesen J; Larsson HBW; Amin FM; Ashina M
Headache; 2019 Oct; 59(9):1468-1480. PubMed ID: 31535367
[TBL] [Abstract][Full Text] [Related]
16. Effect of K
Kokoti L; Al-Karagholi MA; Elbahi FA; Coskun H; Ghanizada H; Amin FM; Ashina M
Cephalalgia; 2022 Aug; 42(9):846-858. PubMed ID: 35301859
[TBL] [Abstract][Full Text] [Related]
17. Arterial responses to infusion of glucagon-like peptide-1 in humans: A randomized trial study.
Ghanizada H; Christensen RH; Al-Karagholi MA; Elbahi FA; Coskun H; Ashina M
Peptides; 2022 Apr; 150():170736. PubMed ID: 35017010
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs.
Wienecke T; Olesen J; Ashina M
Cephalalgia; 2010 Feb; 30(2):179-90. PubMed ID: 19614689
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine.
Rahmann A; Wienecke T; Hansen JM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2008 Mar; 28(3):226-36. PubMed ID: 18254893
[TBL] [Abstract][Full Text] [Related]
20. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
